Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct;37(10):3423-4.
doi: 10.1128/JCM.37.10.3423-3424.1999.

Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy

H Pelloux  1 , H Fricker-Hidalgo, G Brochier, A Goullier-Fleuret, P Ambroise-Thomas
Affiliations

Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy

H Pelloux et al. J Clin Microbiol. 1999 Oct.

Abstract

The serological diagnosis of toxoplasmic infection during pregnancy is intended to prevent congenital infection of the fetus. However, in the context of recurrent pregnancy loss intravenous immunoglobulin therapy can create a biological trap for the interpretation of serological results, with potentially serious consequences for the outcome of the pregnancy.

PubMed Disclaimer

References

    1. De Champs C, Pelloux H, Cambon M, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P. Evaluation of the second generation IMX toxo IgG antibody assay for detection of antibodies to Toxoplasma gondii in human sera. J Clin Lab Anal. 1997;11:214–219. - PMC - PubMed
    1. Fortier B, Ajana F, Valat A S, Bouchez M C. Interférence des immunoglobulines polyvalentes dans la sérologie toxoplasmique. Ann Biol Clin. 1992;50:265–266. - PubMed
    1. Hohlfeld P H, Daffos F, Costa J M, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994;331:695–699. - PubMed
    1. Kiprov D D, Nachtigall R D, Weaver R C, Jacobson A, Main E K, Garovoy M R. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol. 1996;36:228–234. - PubMed
    1. Lichtiger B, Rogge K. Spurious serologic test results in patients receiving infusions of intravenous immune gammaglobulin. Arch Pathol Lab Med. 1991;115:467–469. - PubMed

Substances